.Pfizer RWE VP Lead Clinical Operations in Bothell, United StatesROLE SUMMARY The VP of Clinical Operations in the CMAO RWE Platform leads a global Clinical Operations (C&O; ) organization to support the implementation of observational Pfizer enterprise evidence generation and all Medical Affairs RWE research agendas across all categories and all regions, IDM, EM, and China. In addition, C&O; will oversee operational support for work from PRD and other areas of Pfizer including a broad portfolio of regulatory submission studies for label change, committed PASS, PMS, HTA requirements, and post-marketing commitments.C&O; will conduct studies tosupport the Integrated Evidence Plans (IEP) and strategic goals of all regions including IDM and EM. All study types are within remit including regulatory and non-regulatory Research Collaborations, interventional studies, non-interventional, low interventional, pragmatic, registries, and epidemiological studies. The C&O; VP partners with other RWE Platform VP lines, Category CMAOs, Platform CMAOs, Enterprise VP and Presidents, Medical Affairs leads, Safety, CD&O; , PRD, GSSO, and other leaders in early and late-phase development, Global Health & Value to develop and execute strategies to deliver the IEP study deliverables.The C&O; VP responds to the dynamic business needs to ensure appropriate resourcing across all assets and regions to deliver innovative, high-quality, cost-efficient, clinical and epidemiological studies. The C&O; VP is a Study Matter Expert within observational clinical epidemiology study conduct and as such will provide guidance and oversight of Clinical Operations activities for all TAs. Each TA Clinical Operations Head will report to the C&O; VP.Via collaboration with the RWE Platform Quality and Compliance group, the C&O; VP will establish global consistency, governance, and compliance by developing fit-for-purpose training, oversight, processes/procedures, and updating of existing SOPs to adjust for innovation and high-quality evidence generation. The C&O; VP as part of the RWE Platform and in conjunction with the other Platform functions will build and continuously improve the delivery of high quality, efficient, and consistent evidence generation across the Pfizer enterprise for the main customers including: CMAO, PRD, GAV, and CAI.Strategic Asset Level Across all TAs Determine needs of TAs/CMAOs/International, work cross-functionally to build the Evidence Generation machinery to provide world-class medical data. Oversee the Clinical Operations groups to execute and deliver high-quality studies in accordance with category priority
